Form SC 13G/A Kura Oncology, Inc. Filed by: STATE STREET CORP
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Oncology to Report First Quarter 2024 Financial Results
- Kura Oncology (KURA) Receives Breakthrough Therapy Designation for Ziftomenib
- Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
